Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hallucination And NotYuji Abe

List of bibliographic references

Number of relevant bibliographic references: 34.
Ident.Authors (with country if any)Title
000284 Simon J. G. Lewis [Australie] ; James M. Shine [Australie] ; Shantel Duffy [Australie] ; Glenda Halliday [Australie] ; Sharon L. Naismith [Australie]Anterior Cingulate Integrity: Executive and Neuropsychiatric Features in Parkinson's Disease
000429 Jennifer G. Goldman [États-Unis] ; Darcy Marr [Canada] ; LILI ZHOU [États-Unis] ; Bichun Ouyang [États-Unis] ; Sue E. Leurgans [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; Christopher G. Goetz [États-Unis]Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations
000771 Francisco De Assis Aquino Gondim [Brésil] ; Helida A. Costa [Brésil] ; Tauily C. D. Taunay [Brésil] ; Gisele R. De Oliveira [Brésil] ; Jamile Magalhaes Ferreira [Brésil] ; Francisco H. Rola [Brésil]Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson's Disease
000806 Gilles Fenelon [France] ; Thierry Soulas [France] ; Franck Zenasni [France] ; Laurent Cleret De Langavant [France]The Changing Face of Parkinson's Disease-Associated Psychosis: A Cross-Sectional Study Based on the New NINDS-NIMH Criteria
000943 Christopher G. Goetz [États-Unis]New Developments in Depression, Anxiety, Compulsiveness, and Hallucinations in Parkinson's Disease
000944 Gisela Llebaria [Espagne] ; Javier Pagonabarraga [Espagne] ; Mercè Martinez-Corral [Espagne] ; Carmen Garcia-Sanchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne]Neuropsychological Correlates of Mild to Severe Hallucinations in Parkinson's Disease
000D03 Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Robert Pemeczky [Allemagne] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Giovanni Defazio [Italie] ; Giuseppe Rubini [Italie] ; Paolo Livrea [Italie]Severity of Neuropsychiatric Symptoms and Dopamine Transporter Levels in Dementia with Lewy Bodies: A 123I-FP-CIT SPECT Study
000D88 Dag Aarsland [Norvège, Royaume-Uni] ; Laura Marsh [États-Unis] ; Anette Schrag [Royaume-Uni]Neuropsychiatric Symptoms in Parkinson's Disease
000E16 Naroa Ibarretxe-Bilbao [Espagne] ; Eduardo Tolosa [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Marti [Espagne]MRI and Cognitive Impairment in Parkinson's Disease
001098 Hubert H. Fernandez [États-Unis] ; Dag Aarsland [Norvège] ; Gilles Fenelon [France] ; Joseph H. Friedman [États-Unis] ; Laura Marsh [États-Unis] ; Alexander I. Troster [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Scales to Assess Psychosis in Parkinson's Disease : Critique and Recommendations
001111 Elena Sinforiani [Italie] ; Claudio Pacchetti [Italie] ; Roberta Zangaglia [Italie] ; Chiara Pasotti [Italie] ; Raffaele Manni [Italie] ; Giuseppe Nappi [Italie]REM Behavior Disorder, Hallucinations and Cognitive Impairment in Parkinson's Disease : A Two-Year Follow Up
001127 Jaime Kulisevsky [Espagne] ; Javier Pagonabarraga [Espagne] ; Berta Pascual-Sedano [Espagne] ; Carmen Garcia-Sanchez [Espagne] ; Alexandre Gironell [Espagne]Prevalence and Correlates of Neuropsychiatric Symptoms in Parkinson's Disease Without Dementia
001326 Daisy L. Whitehead [Royaume-Uni] ; Ann D. M. Davies [Royaume-Uni] ; Jeremy R. Playfer [Royaume-Uni] ; Christopher J. Turnbull [Royaume-Uni]Circadian Rest-Activity Rhythm Is Altered in Parkinson's Disease Patients with Hallucinations
001368 Christopher G. Goetz [États-Unis] ; WENQING FAN [États-Unis] ; Sue Leurgans [États-Unis]Antipsychotic Medication Treatment for Mild Hallucinations in Parkinson's Disease : Positive Impact on Long-Term Worsening
001390 Javier Pagonabarraga [Espagne] ; Gisela Llebaria [Espagne] ; Carmen Garcia-Sanchez [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne]A Prospective Study of Delusional Misidentification Syndromes in Parkinson's Disease with Dementia
001833 Gabriella Santangelo [Italie] ; Luigi Trojano [Italie] ; Carmine Vitale [Italie] ; Marta Ianniciello [Italie] ; Marianna Amboni [Italie] ; Dario Grossi [Italie] ; Paolo Barone [Italie]A Neuropsychological Longitudinal Study in Parkinson's Patients With and Without Hallucinations
001929 Elena Sinforiani [Italie] ; Roberta Zangaglia [Italie] ; Raffaele Manni [Italie] ; Silvano Cristina [Italie] ; Enrico Marchioni [Italie] ; Giuseppe Nappi [Italie] ; Francesca Mancini [Italie] ; Claudio Pacchetti [Italie]REM sleep behavior disorder, hallucinations, and cognitive impairment in parkinson's disease
001955 Ergun Y. Uc [États-Unis] ; Lynn K. Struck [États-Unis] ; Robert L. Rodnitzky [États-Unis] ; Bridget Zimmerman [États-Unis] ; Judith Dobson [États-Unis] ; William J. Evans [États-Unis]Predictors of weight loss in Parkinson's disease
001989 Joseph H. Friedman [États-Unis] ; Robert M. Berman [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stewart A. Factor [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; William H. Carson [États-Unis] ; Ronald N. Marcus [États-Unis]Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
001B40 Christopher G. Goetz [États-Unis] ; John Michael Li [États-Unis] ; Joanne Wuu [États-Unis] ; Sue Leurgans [États-Unis]Does seasonal variation affect hallucinations in PD? A longitudinal study
001C45 Christopher G. Goetz [États-Unis] ; Joanne Wuu [États-Unis] ; Linda Curgian [États-Unis] ; Sue Leurgans [États-Unis]Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients
001D30 Claudio Pacchetti [Italie] ; Raffaele Manni [Italie] ; Roberta Zangaglia [Italie] ; Francesca Mancini [Italie] ; Enrico Marchioni [Italie] ; Cristina Tassorelli [Italie] ; Michele Terzaghi [Italie] ; Maria Ossola [Italie] ; Emilia Martignoni [Italie] ; Arrigo Moglia [Italie] ; Giuseppe Nappi [Italie]Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease
001E33 Anne Doe De Maindreville [France] ; Gilles Fenelon [France] ; Florence Mahieux [France]Hallucinations in Parkinson's disease : A follow-up study
001E73 William G. Ondo [États-Unis] ; Ron Tintner [États-Unis] ; Kevin Dat Voung [États-Unis] ; DEJIAN LAI [États-Unis] ; George Ringholz [États-Unis]Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease
001E78 Reinoud C. Klein [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Joeke J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas]Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease
001F29 Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; CHUNHAI HAO [Canada] ; Alex Rajput [Canada]Apolipoprotein E ε4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease : Relationship to dementia and hallucinations
002276 Takashi Nomura [Japon] ; Yuichi Inoue [Japon] ; Hidetaka Mitani [Japon] ; Ryuzo Kawahara [Japon] ; Masahiro Miyake [Japon] ; Kenji Nakashima [Japon]Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease
002443 Marco Onofrj [Italie] ; Anna Lisa Luciano [Italie] ; Diego Iacono [Italie] ; Astrid Thomas [Italie] ; Fabrizio Stocchi [Italie] ; Franco Papola [Italie] ; Domenico Adorno [Italie] ; Rocco Di Mascio [Italie]HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease
002505 Nico J. Diederich [Luxembourg (pays), États-Unis] ; Vannina Pieri [Luxembourg (pays)] ; Christopher G. Goetz [États-Unis]Coping strategies for visual hallucinations in Parkinson's disease
002539 Georg Ebersbach [Allemagne]An artist's view of drug-induced hallucinosis
002672 William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]Olanzapine treatment for dopaminergic-induced hallucinations
002B22 N. A. Leopold [États-Unis]Risperidone treatment of drug-related psychosis in patients with Parkinsonism
002E10 E. J. Pappert [États-Unis] ; C. G. Goetz [États-Unis] ; F. G. Niederman [États-Unis] ; R. Raman [États-Unis] ; S. Leurgans [États-Unis]Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
003962 R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. WilsonClozapine for psychosis in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024